Chronic Kidney Disease Clinical Trials
35 studies are recruiting for chronic kidney disease in the United States right now. Each one is listed on ClinicalTrials.gov, the public registry the research teams themselves file with. TrialBoost is not a doctor, a research site, or a study sponsor: the research team decides who takes part.
Search these by distance from you
By city
Studies, page 2
-
Transcutaneous Auricular Vagus Nerve Stimulation Device in CKD Population
The purpose of this pilot interventional study is to collect preliminary data on the application of a transcutaneous auricular vagal nerve stimulation (taVNS) device in patients with chronic kidney disease (CKD). This data will enhance understanding of the short-term safety, tolerability and effect…
- Stage
- Not phased
- Ages
- 18 to 80
- Site
- NYU Langone Health, New York, New York
- Run by
- NYU Langone Health
-
Intensive Patient Referral and Education Program Prior to Renal Replacement Therapy
Intensive Patient Referral and Education Program prior to Renal Replacement Therapy (iPREP-RRT) is a 12-week intervention that identifies hospitalized African Americans with advanced chronic kidney disease (CKD) and provides them with hospital- and community-based education, navigation and self-man…
- Stage
- Not phased
- Ages
- 18 to 70
- Site
- University of Chicago Medical Center, Chicago, Illinois
- Run by
- University of Chicago
-
Patient-driven Management of BP in CKD
The proposed research will evaluate if patients managing their blood pressure medications under the guidance of a clinical pharmacist works better to lower blood pressure than patients monitoring their blood pressure at home and the standard care. 60 Veterans with chronic kidney disease (CKD) will …
- Stage
- Phase 3
- Ages
- 18 and older
- Site
- Iowa City VA Health Care System, Iowa City, IA, Iowa City, Iowa
- Run by
- VA Office of Research and Development
-
The Impact of Renal Transplant on Coronary Microvascular Function Among Patients With Advanced Chronic Kidney Disease
People with chronic kidney disease (CKD) often experience faster aging of the heart and blood vessels, which raises the risk of heart problems beyond traditional factors like high blood pressure or cholesterol. One early sign is reduced blood flow in the tiny vessels that supply the heart, measured…
- Stage
- Not phased
- Ages
- 18 and older
- Site
- Brigham and Women's Hospital, Boston, Massachusetts
- Run by
- Brigham and Women's Hospital
-
Neurovascular Regulation During Exercise in Humans With Chronic Kidney Disease: Sympatholysis in CKD
The goals of this project are to investigate the mechanisms and potential therapies related to exercise capacity in persons with chronic kidney disease (CKD).
- Stage
- Phase 2
- Ages
- 40 to 75
- Site
- Emory Clinic, Atlanta, Georgia
- Locations
- 2 in total
- Run by
- Emory University
-
The Epidemiology and Pathophysiology of Kidney Disease in HFpEF With Obesity
This research study wants to learn about Chronic Kidney Disease (CKD) with Obesity, and Heart Failure with preserved Ejection Fraction (HFpEF) and better ways to evaluate these diseases. HFpEF means that the heart is not able to fill properly with blood while it is resting so the amount of blood pu…
- Stage
- Not phased
- Ages
- 18 to 75
- Site
- University of Mississippi Medical Center, Jackson, Mississippi
- Run by
- University of Mississippi Medical Center
-
The KidneyCARE (Community Access to Research Equity) Study
For chronic kidney disease (CKD), there is a lack of unique and powerful platform for patient engagement, research studies and public health advocacy work. The National kidney Foundation (NKF) launched the first nationwide registry for people at all stages and types of CKD, including people on dial…
- Stage
- Not phased
- Ages
- 18 to 120
- Site
- Geisinger Clinic, Danville, Pennsylvania
- Run by
- Tufts Medical Center
-
University of Michigan "Nephrology Research BioBank"
The purpose of the study is to create a Nephrology Tissue Biobank enabling the study of kidney disease from the perspectives of epidemiology, genetics and molecular biology.
- Stage
- Not phased
- Ages
- Any age
- Site
- University of Michigan Health System, Ann Arbor, Michigan
- Run by
- University of Michigan
-
Behavioral AI to Predict and Increase Peritoneal Dialysis Uptake
Scaled Insights Behavioral AI will be used to improve clinicians ability to detect and understand: The likelihood of patients with kidney failure opting for peritoneal dialysis and to select the right personalized nudge to get CKD patients to choose peritoneal dialysis Scaled Insights' can utilize …
- Stage
- Not phased
- Ages
- 18 and older
- Site
- Dallas Renal Group, Dallas, Texas
- Run by
- Scaled Insights
-
Clinical Phenotyping Resource and Biobank Core of the Michigan O'Brien Renal Center
Chronic kidney disease (CKD) affects approximately 26 million Americans and disproportionately manifests in specific race and ethnic groups. Patients burdened with CKD have significant morbidity and reduced life expectancy. In addition to excessive suffering and lost productivity, the cost of manag…
- Stage
- Not phased
- Ages
- Any age
- Site
- University of Michigan Health System, Ann Arbor, Michigan
- Locations
- 5 in total
- Run by
- University of Michigan
How to read this page. Every study here comes from ClinicalTrials.gov, the public registry that research teams are required to file with. We have summarised each one in plain language and shown where it is running. We have not changed what any study says it is doing.
What TrialBoost is. We help people find research that might suit them, and, if they ask us to, we pass their details to the research team running it. We are not a doctor, a research site, or a study sponsor, and we do not decide who takes part in anything. Joining costs nothing and you can change your mind at any point.
Paid placement. Some studies pay us when someone asks to be connected to them. Those are labelled Sponsored wherever they appear, and they only appear when they match what you were actually looking for.